Pharmaceutical
Pharmaceutical
When Algorithms Start Prescribing: Who Wins, Who Loses, and What’s at Risk
BY
Maureen Hennessey and Cynthia Miller
Utah’s AI-driven prescription refill pilots are designed to improve access and efficiency, but they raise significant questions about adherence, clinical ...
Pharmaceutical
Regulations and GTN Headline Pharma’s Revenue Management Challenge in 2026
BY
Michael Grosberg
Life sciences companies will spend 2026 grappling with an uncertain regulatory environment and gross-to-net (GTN) management challenges. According to the ...
Pharmaceutical
The 340B Rebate Pause: Why Smart Systems are Still Preparing for Change
BY
Sean Gilman
For many hospitals, the 340B program is more than a regulatory framework, it is a financial stabilizer. The savings generated ...
Pharmaceutical
Why AI and Regulations Will Drive New Drug Development Strategies in 2026
BY
Jim Reilly
Large biopharmas and biotechs have advanced drug development operations by connecting data and processes across the product lifecycle to support ...
Pharmaceutical
When health systems integrate pharmacists into psychiatric care, adherence gaps close and patients benefit
BY
Dr. Alberto Augsten
Adherence to treatments and medications as prescribed is a challenge across diagnoses and clinical contexts. There probably isn’t a disease ...
